Could End-of-Life care for blood cancer patients be done at home?

NCT ID NCT04690205

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests whether a hospital-at-home care model can help people with advanced blood cancers receive end-of-life care at home instead of in the hospital. Participants use remote monitoring and home-based supportive care, with researchers tracking how many enroll and complete daily symptom assessments. The goal is to see if this approach is practical and acceptable for patients, caregivers, and doctors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a hospital-at-home care model with remote monitoring and home-based supportive care
What this could lead to
If successful, this approach could offer a more comfortable, home-based option for end-of-life care in blood cancer patients, potentially improving quality of life.
What could go wrong
This is a small pilot study focused on feasibility, not effectiveness. It may not show clear benefits, and home care may not suit all patients or caregivers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Massachusetts General Hospital Cancer Center

    Boston, Massachusetts, 02114, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.